News Perrigo Company plc

Equities

PRGO

IE00BGH1M568

Real-time Estimate Cboe BZX Other stock markets 01:32:24 2024-05-07 pm EDT			5-day change	1st Jan Change
30.84 ^USD	-7.75%		-5.27%	-3.85%

02:38pm	Perrigo's Q1 Adjusted Earnings, Net Sales Drop	MT
12:47pm	Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 Revenue $1.08B	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Perrigo's Q1 Adjusted Earnings, Net Sales Drop	08:38am	MT
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 Revenue $1.08B	06:47am	MT
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 EPS $0.29, vs. Street Est of $0.23	06:47am	MT
Perrigo: Q1 Earnings Snapshot	06:41am	AQ
Perrigo Company plc Reports Earnings Results for the First Quarter Ended March 30, 2024	06:31am	CI
Perrigo Company plc Reaffirms Earnings Guidance for 2024	06:31am	CI
Perrigo Announces Executive Transition for Its Consumer Self-Care International Business	06:28am	CI
Perrigo Keeps Quarterly Dividend at $0.276 Per Share; Payable June 18 to Shareholders on May 31	May. 01	MT
Perrigo Announces Quarterly Dividend	May. 01	PR
Perrigo Company plc Announces Quarterly Dividend, Payable on June 18, 2024	May. 01	CI
Sector Update: Health Care Stocks Decline Late Afternoon	Apr. 25	MT
Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million	Apr. 25	MT
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million	Apr. 25	PR
Esteve Healthcare S.L. agreed to acquire HRA Pharma Rare Diseases America, LLC from Perrigo Company plc for approximately ?280 million.	Apr. 24	CI
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024	Apr. 23	PR
Opill and WNBA Team Up for Groundbreaking Partnership	Apr. 09	PR
Piper Sandler Raises Perrigo's Price Target to $39 From $35, Maintains Overweight Rating	Apr. 08	MT
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors	Apr. 04	RE
Multiple CVS Caremark Plans to Cover Perrigo's Opill at No Cost	Apr. 04	MT
Multiple CVS Caremark Plans Reportedly to Cover Perrigo's Opill at No Cost	Apr. 04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Perrigo Company plc

Equities

PRGO

IE00BGH1M568

Summary

Filters